Everest Medicines Enters into Asset Purchase Agreement for Etripamil Nasal Spray, Expanding Cardiovascular Footprint Mar 26, 2026 10:49 HKT |  |
|
Formerra Announces Transportation Surcharge to Address Ongoing Freight and Logistics Market Pressures Mar 26, 2026 04:00 HKT |  |
|
Hengrui Pharma Announces Strong 2025 Annual Results Mar 25, 2026 23:15 HKT |  |
|
Wellgistics Health Inc. Signs $105,000,000 Letter of Intent to Evaluate Potential Acquisition of Neuritek Therapeutics, Inc. which is Pioneering Innovative Therapies for Neurological and Psychiatric Disorders Mar 23, 2026 21:05 HKT |  |
|
Essex Bio-Technology Reports Robust Results for FY2025, Turnover Soars 8.6% to HK$1814 million, Net Profit up 3.5% to HK$ 318.1 million, Total Dividend Increases by 16.7% to HK14 Cents per Share Mar 23, 2026 20:51 HKT |  |
|
Affiliate of Pacific Avenue Capital Partners Completes Acquisition of Care.com from IAC Mar 19, 2026 15:15 HKT |  |
|
CMS (867.HK/8A8.SG) : New Drug for Renal Anaemia Desidustat Tablets Approved in China Mar 13, 2026 22:00 HKT |  |
|
CMS (867.HK/8A8.SG): Ruxolitinib Phosphate Cream (Lumirix(R)) Achieves Initial Prescriptions in Multiple Regions in China for Patients with Vitiligo Mar 13, 2026 17:00 HKT |  |
|
OMRON Healthcare releases new Women's Heart Health Factbook Mar 09, 2026 06:00 HKT |  |
|
CMS (867.HK/8A8.SG): Self-Developed INHBE-Targeting siRNA Drug Received IND Approval for Overweight/Obesity Mar 05, 2026 16:00 HKT |  |
|
Formerra Appoints Tom Kelly as Chief Executive Officer Mar 04, 2026 21:00 HKT |  |
|
Hua Medicine Announces the Approval of Dorzagliatin for Marketing in Hong Kong SAR, China Mar 03, 2026 12:14 HKT |  |
|
analytica Hanoi 2026 Makes Its Debut, Bringing the Global Science and Laboratory Platform to Northern Vietnam Feb 25, 2026 19:57 HKT |  |
|
CMS (867.HK/8A8.SG): NDA for Additional Indication Atopic Dermatitis (AD) for Ruxolitinib Phosphate Cream Accepted and Granted Priority Review in China Feb 24, 2026 21:30 HKT |  |
|
CanSinoBIO's Menhycia(R) Secures Expanded Age Indication, Unlock Broader Long-Term Growth Potential Feb 24, 2026 18:22 HKT |  |
|
Bioxytran Initiates Research Collaboration with University of Georgia to Evaluate Drug Candidate's Ability to Block H5N1 Bird Flu Virus Feb 23, 2026 20:00 HKT |  |
|
Modern Dental Group Celebrates 40 Years: 'Redefining Smiles. The Digital Way.' Feb 13, 2026 10:31 HKT |  |
|
Bioxytran Reports Positive Phase 2 Results Demonstrating Rapid Viral Clearance with ProLectin-MBioxytran Feb 11, 2026 19:00 HKT |  |
|
EssexBio Bolsters Commitment to Ophthalmology Innovation at APAO 2026 in Hong Kong Feb 10, 2026 18:14 HKT |  |
|
GIC Invests US$100M in Ascletis Pharma (1672. HK): Anchoring Long-Term Capital in China's Core Innovative Drug Assets Feb 06, 2026 17:45 HKT |  |
|